BioCentury
ARTICLE | Clinical News

AVM starts Phase II contrast agent study

January 24, 2001 8:00 AM UTC

Advanced Magnetics (AVM) began U.S. Phase II testing of its Code 7228 iron oxide-coated MRI contrast agent for use in magnetic angiography. ...